Ignite Creation Date:
2025-12-25 @ 3:15 AM
Ignite Modification Date:
2025-12-31 @ 8:02 PM
Study NCT ID:
NCT06988605
Status:
RECRUITING
Last Update Posted:
2025-11-19
First Post:
2025-05-16
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Real-world Experience Using Nemolizumab in the Treatment of Moderate-to-Severe Atopic Dermatitis in Adolescents & Adults
Sponsor:
Organization:
Raw JSON
{'hasResults': False, 'derivedSection': {'miscInfoModule': {'versionHolder': '2025-12-24'}, 'conditionBrowseModule': {'meshes': [{'id': 'D003876', 'term': 'Dermatitis, Atopic'}], 'ancestors': [{'id': 'D012873', 'term': 'Skin Diseases, Genetic'}, {'id': 'D030342', 'term': 'Genetic Diseases, Inborn'}, {'id': 'D009358', 'term': 'Congenital, Hereditary, and Neonatal Diseases and Abnormalities'}, {'id': 'D003872', 'term': 'Dermatitis'}, {'id': 'D012871', 'term': 'Skin Diseases'}, {'id': 'D017437', 'term': 'Skin and Connective Tissue Diseases'}, {'id': 'D017443', 'term': 'Skin Diseases, Eczematous'}, {'id': 'D006969', 'term': 'Hypersensitivity, Immediate'}, {'id': 'D006967', 'term': 'Hypersensitivity'}, {'id': 'D007154', 'term': 'Immune System Diseases'}]}}, 'protocolSection': {'designModule': {'studyType': 'OBSERVATIONAL', 'designInfo': {'timePerspective': 'PROSPECTIVE', 'observationalModel': 'OTHER'}, 'enrollmentInfo': {'type': 'ESTIMATED', 'count': 1000}, 'patientRegistry': False}, 'statusModule': {'overallStatus': 'RECRUITING', 'startDateStruct': {'date': '2025-07-14', 'type': 'ACTUAL'}, 'expandedAccessInfo': {'hasExpandedAccess': False}, 'statusVerifiedDate': '2025-11', 'completionDateStruct': {'date': '2027-11-30', 'type': 'ESTIMATED'}, 'lastUpdateSubmitDate': '2025-11-17', 'studyFirstSubmitDate': '2025-05-16', 'studyFirstSubmitQcDate': '2025-05-16', 'lastUpdatePostDateStruct': {'date': '2025-11-19', 'type': 'ESTIMATED'}, 'studyFirstPostDateStruct': {'date': '2025-05-25', 'type': 'ACTUAL'}, 'primaryCompletionDateStruct': {'date': '2026-11-06', 'type': 'ESTIMATED'}}, 'outcomesModule': {'primaryOutcomes': [{'measure': 'Investigator Global Assessment (IGA) at Month 6', 'timeFrame': 'At Month 6', 'description': 'The IGA is a 5-point scale ranging from 0 (clear) to 4 (severe) used by the investigator or trained designee to evaluate the global severity of AD and the clinical response to a treatment.'}, {'measure': 'Peak Pruritus Numerical Rating Scale (PP NRS) at Month 6', 'timeFrame': 'At Month 6', 'description': 'The PP NRS is a single question validated PRO assessment that participants will use to report the maximum intensity of their pruritus (itch). The PP NRS consists of the following question: "On a scale of 0 to 10, with 0 being \'no itch\' and 10 being the \'worst itch imaginable\', how would you rate your itch at the worst moment during the previous 24 hours?". Here, a lower score indicates a better outcome.'}], 'secondaryOutcomes': [{'measure': 'Eczema Area and Severity Index (EASI) up to Month 12', 'timeFrame': 'Up to Month 12', 'description': 'The EASI is a validated measure commonly used in clinical trials and clinical practice to assess the severity and the extent of AD signs. The EASI score is a composite score ranging from 0 to 72. The severity of erythema, induration/papulation, excoriation, and lichenification will be assessed by the investigator or trained designee on a scale of 0 (absent) to 3 (severe) for each of the 4 body areas: head/neck, trunk, upper limbs, and lower limbs, with half points allowed. In addition, the extent of AD involvement in each of the 4 body areas will be assessed as a percentage by body area of head, trunk, upper limbs, and lower limbs, and converted to a score of 0 to 6. A higher score indicates severe AD.'}, {'measure': 'Scoring Atopic Dermatitis (SCORAD) up to Month 12', 'timeFrame': 'Up to Month 12', 'description': 'The SCORAD is a validated measure commonly used in clinical trials and clinical practice to assess the severity and the extent of AD signs and symptoms. The SCORAD ranges from 0 to 103 and has 3 components: extent, intensity, and patient-reported symptoms of pruritus and sleep loss. The investigator or trained designee will assess the severity of 6 signs of AD (erythema, edema/papulation, oozing/crust, excoriation, lichenification, and dryness), each on a scale ranging from 0 (absence) to 3 (severe). The investigator or trained designee will also ask the participant to evaluate their symptoms of pruritus and sleep loss (average for the last 3 days/nights), each evaluated on a visual analogue scale (VAS) from 0 to 10. A higher score indicates severe AD.'}, {'measure': 'Investigator Global Assessment (IGA) up to Month 12', 'timeFrame': 'Up to Month 12', 'description': 'The IGA is a 5-point scale ranging from 0 (clear) to 4 (severe) used by the investigator or trained designee to evaluate the global severity of AD and the clinical response to a treatment.'}, {'measure': 'Peak Pruritus Numerical Rating Scale (PP NRS) up to Month 12', 'timeFrame': 'Up to Month 12', 'description': 'The PP NRS is a single question validated PRO assessment that participants will use to report the maximum intensity of their pruritus (itch). The PP NRS consists of the following question: "On a scale of 0 to 10, with 0 being \'no itch\' and 10 being the \'worst itch imaginable\', how would you rate your itch at the worst moment during the previous 24 hours?". Here, a lower score indicates a better outcome.'}, {'measure': 'Average Pruritus Numerical Rating Scale (AP NRS) up to Month 12', 'timeFrame': 'Up to Month 12', 'description': 'The AP NRS is a single question assessment that participants will use to report the average intensity of their pruritus (itch). The AP NRS consists of the following question: "On a scale of 0 to 10, with 0 being \'no itch\' and 10 being the \'worst itch imaginable\', how would you rate your itch overall during the previous 24 hours?". Here, a lower score indicates a better outcome.'}, {'measure': 'Sleep Disturbance Numerical Rating Scale (SD NRS) up to Month 12', 'timeFrame': 'Up to Month 12', 'description': 'The SD NRS is a single-item PRO for quantifying sleep disturbance. The SD NRS consists of the following question: "On a scale of 0 to 10, with 0 being \'no sleep loss related to the symptoms of my skin disease (atopic dermatitis)\' and 10 being \'I did not sleep at all due to the symptoms of my skin disease (atopic dermatitis)\', how would you rate your sleep last night?". Here, a lower score indicates a better outcome.'}, {'measure': 'Pain Numerical Rating Scale (Pain NRS) up to Month 12', 'timeFrame': 'Up to Month 12', 'description': 'The Pain NRS is a single-item assessment with a potential follow-up question that participants will use to report the average intensity of their pain. The Pain NRS consists of the following question: "Over the past 24 hours, how severe was the pain in your skin?". If the participant rates their pain from 1 to 10, then the following question will be asked: "Do you think the pain is part of the itch, from scratching or both?". Here, a lower score indicates a better outcome.'}]}, 'oversightModule': {'oversightHasDmc': False, 'isFdaRegulatedDrug': False, 'isFdaRegulatedDevice': False}, 'conditionsModule': {'conditions': ['Atopic Dermatitis']}, 'descriptionModule': {'briefSummary': 'The main aim of the study is to assess real-world effectiveness of nemolizumab in Atopic Dermatitis (AD) as measured by physician assessment and patient reported outcome (PRO) in clinical practice at Month 6.', 'detailedDescription': "This prospective, multicenter, non-interventional study (NIS) seeks to evaluate treatment with nemolizumab of moderate-to-severe AD in adolescents and adults over an approximately 12-month period using physician assessments in routine clinical practice and PRO measures.\n\nTreatment with nemolizumab will be determined solely by the participant's physician prior to study enrollment. No additional visits, procedures, or laboratory tests are required outside of routine clinical practice. The visit structure is not defined by the study protocol but is determined by routine medical practice. The visit schedule is intended to facilitate a systematic data assessment according to clinical routine. A sub-study will be completed in Germany and the UK at selected sites in which participants will complete the Peak Pruritus (PP) Numerical Rating Scale (NRS), Average Pruritus (AP) NRS, Sleep Disturbance (SD) NRS, and Pain NRS on a daily basis from Day -1 to Day 14. Data collection will occur remotely, and no clinic visits will be required."}, 'eligibilityModule': {'sex': 'ALL', 'stdAges': ['CHILD', 'ADULT', 'OLDER_ADULT'], 'minimumAge': '12 Years', 'samplingMethod': 'NON_PROBABILITY_SAMPLE', 'studyPopulation': 'The clinical decision for treatment with nemolizumab has to be made by the physicians independently of the participation in this NIS and prior to the informed consent process. Participants greater than or equal to (\\>=) 12 years of age will be eligible for the trial.', 'healthyVolunteers': False, 'eligibilityCriteria': "Inclusion Criteria:\n\n* Participants who, according to the treating physician's decision and in line with the local package label, start treatment with nemolizumab (Nemluvio®).\n* Adolescent and adult participants aged \\>=12 years with moderate-to-severe AD.\n* Participants who signed the written informed consent form (ICF) or had it signed by their legal representative.\n\nExclusion Criteria:\n\n* Have contraindication(s) for the use of nemolizumab (Nemluvio®) according to the local package label.\n* Participants who received treatment with a drug under clinical development/investigation within 3 months prior to baseline.\n* Participants who received nemolizumab previously.\n* Participants who are mentally, physically, or linguistically unable to understand the content of the ICF and/or to complete the study questionnaires."}, 'identificationModule': {'nctId': 'NCT06988605', 'acronym': 'RE-UNITE AD', 'briefTitle': 'Real-world Experience Using Nemolizumab in the Treatment of Moderate-to-Severe Atopic Dermatitis in Adolescents & Adults', 'organization': {'class': 'INDUSTRY', 'fullName': 'Galderma R&D'}, 'officialTitle': 'Real-world Experience Using Nemolizumab in the Treatment of Moderate-to-Severe Atopic Dermatitis in Adolescents & Adults', 'orgStudyIdInfo': {'id': 'SPR207806'}}, 'armsInterventionsModule': {'armGroups': [{'label': 'Nemolizumab', 'description': 'Participants with moderate-to-severe AD who are receiving nemolizumab (Nemluvio®) in routine clinical practice will be observed for approximately 12 months.'}]}, 'contactsLocationsModule': {'locations': [{'zip': '35244', 'city': 'Birmingham', 'state': 'Alabama', 'status': 'RECRUITING', 'country': 'United States', 'facility': 'Galderma Investigational Site - 8893', 'geoPoint': {'lat': 33.52066, 'lon': -86.80249}}, {'zip': '85006-2754', 'city': 'Phoenix', 'state': 'Arizona', 'status': 'NOT_YET_RECRUITING', 'country': 'United States', 'facility': 'Galdrma Investigational Site - 7077', 'geoPoint': {'lat': 33.44838, 'lon': -112.07404}}, {'zip': '85008-3884', 'city': 'Phoenix', 'state': 'Arizona', 'status': 'RECRUITING', 'country': 'United States', 'facility': 'Galderma Investigational Site 7060', 'geoPoint': {'lat': 33.44838, 'lon': -112.07404}}, {'zip': '85032-2238', 'city': 'Phoenix', 'state': 'Arizona', 'status': 'ACTIVE_NOT_RECRUITING', 'country': 'United States', 'facility': 'Galderma Investigational Site - 8535', 'geoPoint': {'lat': 33.44838, 'lon': -112.07404}}, {'zip': '85718', 'city': 'Tucson', 'state': 'Arizona', 'status': 'RECRUITING', 'country': 'United States', 'facility': 'Galderma Investigational Site - 7067', 'geoPoint': {'lat': 32.22174, 'lon': -110.92648}}, {'zip': '92882', 'city': 'Corona', 'state': 'California', 'status': 'RECRUITING', 'country': 'United States', 'facility': 'Galderma Investigational Site - 7074', 'geoPoint': {'lat': 33.87529, 'lon': -117.56644}}, {'zip': '92708-3701', 'city': 'Fountain Valley', 'state': 'California', 'status': 'RECRUITING', 'country': 'United States', 'facility': 'Galderma Investigational Site 6836', 'geoPoint': {'lat': 33.70918, 'lon': -117.95367}}, {'zip': '94538-1603', 'city': 'Fremont', 'state': 'California', 'status': 'NOT_YET_RECRUITING', 'country': 'United States', 'facility': 'Galderma Investigational Site 8224', 'geoPoint': {'lat': 37.54827, 'lon': -121.98857}}, {'zip': '92697', 'city': 'Irvine', 'state': 'California', 'status': 'RECRUITING', 'country': 'United States', 'facility': 'Galderma Investigational Site 7100', 'geoPoint': {'lat': 33.66946, 'lon': -117.82311}}, {'zip': '90024-2801', 'city': 'Los Angeles', 'state': 'California', 'status': 'RECRUITING', 'country': 'United States', 'facility': 'Galderma Investigational Site 7099', 'geoPoint': {'lat': 34.05223, 'lon': -118.24368}}, {'zip': '92663-3606', 'city': 'Newport Beach', 'state': 'California', 'status': 'NOT_YET_RECRUITING', 'country': 'United States', 'facility': 'Galderma Investigational Site 8553', 'geoPoint': {'lat': 33.61891, 'lon': -117.92895}}, {'zip': '94115-3011', 'city': 'San Francisco', 'state': 'California', 'status': 'RECRUITING', 'country': 'United States', 'facility': 'Galderma Investigational Site 6836', 'geoPoint': {'lat': 37.77493, 'lon': -122.41942}}, {'zip': '90404-2216', 'city': 'Santa Monica', 'state': 'California', 'status': 'RECRUITING', 'country': 'United States', 'facility': 'Galderma Investigational Site', 'geoPoint': {'lat': 34.01949, 'lon': -118.49138}}, {'zip': '91360-7746', 'city': 'Thousand Oaks', 'state': 'California', 'status': 'RECRUITING', 'country': 'United States', 'facility': 'Galderma Investigational Site 7107', 'geoPoint': {'lat': 34.17056, 'lon': -118.83759}}, {'zip': '80109-8034', 'city': 'Castle Rock', 'state': 'Colorado', 'status': 'RECRUITING', 'country': 'United States', 'contacts': [{'name': 'Clinical Project Manager', 'role': 'CONTACT'}], 'facility': 'Galderma Investigational Site 7061', 'geoPoint': {'lat': 39.37221, 'lon': -104.85609}}, {'zip': '76824', 'city': 'Fairfield', 'state': 'Connecticut', 'status': 'NOT_YET_RECRUITING', 'country': 'United States', 'contacts': [{'name': 'Clinical Project Manager', 'role': 'CONTACT'}], 'facility': 'Galderma Investigational Site 7059', 'geoPoint': {'lat': 41.14121, 'lon': -73.26373}}, {'zip': '33134-2073', 'city': 'Coral Gables', 'state': 'Florida', 'status': 'RECRUITING', 'country': 'United States', 'facility': 'Galderma Investigational Site 7105', 'geoPoint': {'lat': 25.72149, 'lon': -80.26838}}, {'zip': '33157', 'city': 'Cutler Bay', 'state': 'Florida', 'status': 'RECRUITING', 'country': 'United States', 'contacts': [{'name': 'Clinical Project Manager', 'role': 'CONTACT'}], 'facility': 'Galderma Investigational Site 7063', 'geoPoint': {'lat': 25.5783, 'lon': -80.3377}}, {'zip': '33477', 'city': 'Jupiter', 'state': 'Florida', 'status': 'RECRUITING', 'country': 'United States', 'facility': 'Galderma Investigational Site 7101', 'geoPoint': {'lat': 26.93422, 'lon': -80.09421}}, {'zip': '33137', 'city': 'Miami', 'state': 'Florida', 'status': 'RECRUITING', 'country': 'United States', 'facility': 'Galderma Investigational Site 7021', 'geoPoint': {'lat': 25.77427, 'lon': -80.19366}}, {'zip': '33173-3255', 'city': 'Miami', 'state': 'Florida', 'status': 'RECRUITING', 'country': 'United States', 'facility': 'Galderma Investigational Site 7084', 'geoPoint': {'lat': 25.77427, 'lon': -80.19366}}, {'zip': '33173', 'city': 'Miami', 'state': 'Florida', 'status': 'RECRUITING', 'country': 'United States', 'facility': 'Galderma Investigational Site 7078', 'geoPoint': {'lat': 25.77427, 'lon': -80.19366}}, {'zip': '33162-4708', 'city': 'North Miami Beach', 'state': 'Florida', 'status': 'RECRUITING', 'country': 'United States', 'facility': 'Galderma Investigational Site 7070', 'geoPoint': {'lat': 25.93315, 'lon': -80.16255}}, {'zip': '33713-8012', 'city': 'St. Petersburg', 'state': 'Florida', 'status': 'RECRUITING', 'country': 'United States', 'facility': 'Galderma Investigational Site 7090', 'geoPoint': {'lat': 27.77086, 'lon': -82.67927}}, {'zip': '33431-5133', 'city': 'Tampa', 'state': 'Florida', 'status': 'RECRUITING', 'country': 'United States', 'facility': 'Galderma Investigational Site 7054', 'geoPoint': {'lat': 27.94752, 'lon': -82.45843}}, {'zip': '33609-2230', 'city': 'Tampa', 'state': 'Florida', 'status': 'RECRUITING', 'country': 'United States', 'facility': 'Galderma Investigational Site 7054', 'geoPoint': {'lat': 27.94752, 'lon': -82.45843}}, {'zip': '33615-4537', 'city': 'Tampa', 'state': 'Florida', 'status': 'RECRUITING', 'country': 'United States', 'facility': 'Galderma Investigational Site 7091', 'geoPoint': {'lat': 27.94752, 'lon': -82.45843}}, {'zip': '60641', 'city': 'Chicago', 'state': 'Illinois', 'status': 'RECRUITING', 'country': 'United States', 'facility': 'Galderma Investigational Site 7058', 'geoPoint': {'lat': 41.85003, 'lon': -87.65005}}, {'zip': '46250-2041', 'city': 'Indianapolis', 'state': 'Indiana', 'status': 'RECRUITING', 'country': 'United States', 'facility': 'Galderma Investigational Site 8142', 'geoPoint': {'lat': 39.76838, 'lon': -86.15804}}, {'zip': '47906-1569', 'city': 'West Lafayette', 'state': 'Indiana', 'status': 'RECRUITING', 'country': 'United States', 'facility': 'Galderma Investigational Site 7083', 'geoPoint': {'lat': 40.42587, 'lon': -86.90807}}, {'zip': '21045-2336', 'city': 'Columbia', 'state': 'Maryland', 'status': 'RECRUITING', 'country': 'United States', 'facility': 'Galderma Investigational Site 7098', 'geoPoint': {'lat': 39.24038, 'lon': -76.83942}}, {'zip': '20769-9182', 'city': 'Glenn Dale', 'state': 'Maryland', 'status': 'RECRUITING', 'country': 'United States', 'facility': 'Galderma Investigational Site 8012', 'geoPoint': {'lat': 38.98761, 'lon': -76.82053}}, {'zip': '20850-6243', 'city': 'Rockville', 'state': 'Maryland', 'status': 'RECRUITING', 'country': 'United States', 'facility': 'Galderma Investigational Site 7068', 'geoPoint': {'lat': 39.084, 'lon': -77.15276}}, {'zip': '02135', 'city': 'Brighton', 'state': 'Massachusetts', 'status': 'RECRUITING', 'country': 'United States', 'contacts': [{'name': 'Clinical Project Manager', 'role': 'CONTACT'}], 'facility': 'Galderma Investigational Site 7065', 'geoPoint': {'lat': 42.3501, 'lon': -71.15644}}, {'zip': '01757', 'city': 'Milford', 'state': 'Massachusetts', 'status': 'RECRUITING', 'country': 'United States', 'facility': 'Galderma Investigationa Site 7104', 'geoPoint': {'lat': 42.13982, 'lon': -71.51617}}, {'zip': '48326-3396', 'city': 'Auburn Hills', 'state': 'Michigan', 'status': 'RECRUITING', 'country': 'United States', 'facility': 'Galderma Investigational Site 7066', 'geoPoint': {'lat': 42.68753, 'lon': -83.2341}}, {'zip': '49316-7478', 'city': 'Caledonia', 'state': 'Michigan', 'status': 'RECRUITING', 'country': 'United States', 'facility': 'Galderma Investigational Site 7071', 'geoPoint': {'lat': 42.7892, 'lon': -85.51669}}, {'zip': '49418', 'city': 'Grandville', 'state': 'Michigan', 'status': 'RECRUITING', 'country': 'United States', 'facility': 'Galderma Investigational Site 7108', 'geoPoint': {'lat': 42.90975, 'lon': -85.76309}}, {'zip': '48084-5260', 'city': 'Troy', 'state': 'Michigan', 'status': 'NOT_YET_RECRUITING', 'country': 'United States', 'facility': 'Galderma Investigational Site 7072', 'geoPoint': {'lat': 42.60559, 'lon': -83.14993}}, {'zip': '64064', 'city': "Lee's Summit", 'state': 'Missouri', 'status': 'NOT_YET_RECRUITING', 'country': 'United States', 'contacts': [{'name': 'Clinical Project Manager', 'role': 'CONTACT'}], 'facility': 'Galderma Investigational Site 7057', 'geoPoint': {'lat': 38.91084, 'lon': -94.38217}}, {'zip': '63141-7068', 'city': 'St Louis', 'state': 'Missouri', 'status': 'RECRUITING', 'country': 'United States', 'facility': 'Galderma Investigational Site 7076', 'geoPoint': {'lat': 38.62727, 'lon': -90.19789}}, {'zip': '89144-0518', 'city': 'Las Vegas', 'state': 'Nevada', 'status': 'RECRUITING', 'country': 'United States', 'facility': 'Galderma Investigational Site 8848', 'geoPoint': {'lat': 36.17497, 'lon': -115.13722}}, {'zip': '03801-7156', 'city': 'Portsmouth', 'state': 'New Hampshire', 'status': 'RECRUITING', 'country': 'United States', 'facility': 'Galderma Investigational Site 7055', 'geoPoint': {'lat': 43.07704, 'lon': -70.75766}}, {'zip': '13021', 'city': 'Auburn', 'state': 'New York', 'status': 'RECRUITING', 'country': 'United States', 'facility': 'Galderma Investigational Site - Site 7080', 'geoPoint': {'lat': 42.93173, 'lon': -76.56605}}, {'zip': '13057', 'city': 'East Syracuse', 'state': 'New York', 'status': 'NOT_YET_RECRUITING', 'country': 'United States', 'contacts': [{'name': 'Clinical Project Manager', 'role': 'CONTACT'}], 'facility': 'Galderma Investigational Site # 7052', 'geoPoint': {'lat': 43.06534, 'lon': -76.07853}}, {'zip': '10549-3035', 'city': 'Mount Kisco', 'state': 'New York', 'status': 'NOT_YET_RECRUITING', 'country': 'United States', 'facility': 'Galderma Investigational Site - 8282', 'geoPoint': {'lat': 41.20426, 'lon': -73.72708}}, {'zip': '10023', 'city': 'New York', 'state': 'New York', 'status': 'RECRUITING', 'country': 'United States', 'facility': 'Galderma Investigational Site - 7051', 'geoPoint': {'lat': 40.71427, 'lon': -74.00597}}, {'zip': '10028', 'city': 'New York', 'state': 'New York', 'status': 'RECRUITING', 'country': 'United States', 'facility': 'Galderma Investigational Site 7109', 'geoPoint': {'lat': 40.71427, 'lon': -74.00597}}, {'zip': '10075-0337', 'city': 'New York', 'state': 'New York', 'status': 'RECRUITING', 'country': 'United States', 'facility': 'Galderma Investigational Site 8279', 'geoPoint': {'lat': 40.71427, 'lon': -74.00597}}, {'zip': '45414-2799', 'city': 'Dayton', 'state': 'Ohio', 'status': 'RECRUITING', 'country': 'United States', 'facility': 'Galderma Investigational Site 7081', 'geoPoint': {'lat': 39.75895, 'lon': -84.19161}}, {'zip': '97030-2923', 'city': 'Gresham', 'state': 'Oregon', 'status': 'RECRUITING', 'country': 'United States', 'facility': 'Galderma Investigational Site 7073', 'geoPoint': {'lat': 45.49818, 'lon': -122.43148}}, {'zip': '19103-4738', 'city': 'Philadelphia', 'state': 'Pennsylvania', 'status': 'RECRUITING', 'country': 'United States', 'facility': 'Galderma Investigational Site 8559', 'geoPoint': {'lat': 39.95238, 'lon': -75.16362}}, {'zip': '19104', 'city': 'Philadelphia', 'state': 'Pennsylvania', 'status': 'RECRUITING', 'country': 'United States', 'facility': 'Galderma Investigational Site 7103', 'geoPoint': {'lat': 39.95238, 'lon': -75.16362}}, {'zip': '29910', 'city': 'Bluffton', 'state': 'South Carolina', 'status': 'RECRUITING', 'country': 'United States', 'facility': 'Galderma Investigational Site 7106', 'geoPoint': {'lat': 32.23715, 'lon': -80.86039}}, {'zip': '78613-7875', 'city': 'Cedar Park', 'state': 'Texas', 'status': 'RECRUITING', 'country': 'United States', 'facility': 'Galderma Investigational Site 7082', 'geoPoint': {'lat': 30.5052, 'lon': -97.82029}}, {'zip': '75230-5808', 'city': 'Dallas', 'state': 'Texas', 'status': 'RECRUITING', 'country': 'United States', 'facility': 'Galderma Investigational Site 8238', 'geoPoint': {'lat': 32.78306, 'lon': -96.80667}}, {'zip': '78539-4660', 'city': 'Edinburg', 'state': 'Texas', 'status': 'RECRUITING', 'country': 'United States', 'facility': 'Galderma Investigational Site 7062', 'geoPoint': {'lat': 26.30174, 'lon': -98.16334}}, {'zip': '76051', 'city': 'Grapevine', 'state': 'Texas', 'status': 'RECRUITING', 'country': 'United States', 'facility': 'Galderma Investigational Site 7088', 'geoPoint': {'lat': 32.93429, 'lon': -97.07807}}, {'zip': '77004-8098', 'city': 'Houston', 'state': 'Texas', 'status': 'RECRUITING', 'country': 'United States', 'facility': 'Galderma Investigational Site 7102', 'geoPoint': {'lat': 29.76328, 'lon': -95.36327}}, {'zip': '77478-3842', 'city': 'Sugar Land', 'state': 'Texas', 'status': 'RECRUITING', 'country': 'United States', 'facility': 'Galderma Investigational Site 7069', 'geoPoint': {'lat': 29.61968, 'lon': -95.63495}}, {'zip': '76710-4023', 'city': 'Waco', 'state': 'Texas', 'status': 'RECRUITING', 'country': 'United States', 'facility': 'Galderma Investigational Site 8618', 'geoPoint': {'lat': 31.54933, 'lon': -97.14667}}, {'zip': '84010-4801', 'city': 'Bountiful', 'state': 'Utah', 'status': 'RECRUITING', 'country': 'United States', 'facility': 'Galderma Investigational Site 7085', 'geoPoint': {'lat': 40.88939, 'lon': -111.88077}}, {'zip': '22182', 'city': 'Vienna', 'state': 'Virginia', 'status': 'RECRUITING', 'country': 'United States', 'facility': 'Galderma Investigational Site 7079', 'geoPoint': {'lat': 38.90122, 'lon': -77.26526}}, {'zip': '76133', 'city': 'Karlsruhe', 'state': 'Baden-Wurttemberg', 'status': 'RECRUITING', 'country': 'Germany', 'facility': 'Galderma Investigational Site 6374', 'geoPoint': {'lat': 49.00937, 'lon': 8.40444}}, {'zip': '89129', 'city': 'Langenau', 'state': 'Baden-Wurttemberg', 'status': 'RECRUITING', 'country': 'Germany', 'facility': 'Galderma Investigational Site 6412', 'geoPoint': {'lat': 48.49616, 'lon': 10.11849}}, {'zip': '86179', 'city': 'Augsburg', 'state': 'Bavaria', 'status': 'RECRUITING', 'country': 'Germany', 'facility': 'Galderma Investigational Site 6416', 'geoPoint': {'lat': 48.37154, 'lon': 10.89851}}, {'zip': '91054', 'city': 'Erlangen', 'state': 'Bavaria', 'status': 'RECRUITING', 'country': 'Germany', 'facility': 'Galderma Investigational Site 6369', 'geoPoint': {'lat': 49.59099, 'lon': 11.00783}}, {'zip': '93053', 'city': 'Regensburg', 'state': 'Bavaria', 'status': 'RECRUITING', 'country': 'Germany', 'facility': 'Galderma Investigational Site 6417', 'geoPoint': {'lat': 49.01513, 'lon': 12.10161}}, {'zip': '42897', 'city': 'Remscheid', 'state': 'North Rhine-Westphalia', 'status': 'RECRUITING', 'country': 'Germany', 'facility': 'Galderma Investigational Site 6419', 'geoPoint': {'lat': 51.17983, 'lon': 7.1925}}, {'zip': '48683', 'city': 'Ahaus', 'status': 'RECRUITING', 'country': 'Germany', 'facility': 'Galderma Investigational Site 6387', 'geoPoint': {'lat': 52.07936, 'lon': 7.01344}}, {'zip': '86150', 'city': 'Augsburg', 'status': 'RECRUITING', 'country': 'Germany', 'facility': 'Galderma Investigational Site 6383', 'geoPoint': {'lat': 48.37154, 'lon': 10.89851}}, {'zip': '10117', 'city': 'Berlin', 'status': 'RECRUITING', 'country': 'Germany', 'facility': 'Galderma Investigational Site 6385', 'geoPoint': {'lat': 52.52437, 'lon': 13.41053}}, {'zip': '12203', 'city': 'Berlin', 'status': 'RECRUITING', 'country': 'Germany', 'contacts': [{'name': 'Clinial Project Manager', 'role': 'CONTACT'}], 'facility': 'Galderma Investigative Site 6172', 'geoPoint': {'lat': 52.52437, 'lon': 13.41053}}, {'zip': '13086', 'city': 'Berlin', 'status': 'RECRUITING', 'country': 'Germany', 'facility': 'Galderma Investigational Site 6366', 'geoPoint': {'lat': 52.52437, 'lon': 13.41053}}, {'zip': '16321', 'city': 'Bernau bei Berlin', 'status': 'RECRUITING', 'country': 'Germany', 'facility': 'Galderma Investigational Site 6398', 'geoPoint': {'lat': 52.67982, 'lon': 13.58708}}, {'zip': '33647', 'city': 'Bielefeld', 'status': 'RECRUITING', 'country': 'Germany', 'facility': 'Galderma Investigational Site 6386', 'geoPoint': {'lat': 52.03333, 'lon': 8.53333}}, {'zip': '21614', 'city': 'Buxtehude', 'status': 'RECRUITING', 'country': 'Germany', 'contacts': [{'name': 'Clinical Project Manager', 'role': 'CONTACT'}], 'facility': 'Galderma Investigational Site 6066', 'geoPoint': {'lat': 53.46994, 'lon': 9.68968}}, {'zip': '45964', 'city': 'Gladbeck', 'status': 'RECRUITING', 'country': 'Germany', 'facility': 'Galderma Investigational Site 6414', 'geoPoint': {'lat': 51.57077, 'lon': 6.98593}}, {'zip': '1558', 'city': 'Großenhain', 'status': 'RECRUITING', 'country': 'Germany', 'facility': 'Galderma Investigational Site 6418', 'geoPoint': {'lat': 51.28951, 'lon': 13.5335}}, {'zip': '77716', 'city': 'Haslach im Kinzigtal', 'status': 'RECRUITING', 'country': 'Germany', 'facility': 'Galderma Investigational Site 6370', 'geoPoint': {'lat': 48.27773, 'lon': 8.08941}}, {'zip': '91217', 'city': 'Hersbruck', 'status': 'RECRUITING', 'country': 'Germany', 'facility': 'Galderma Investigational Site 6420', 'geoPoint': {'lat': 49.51083, 'lon': 11.43151}}, {'zip': '56068', 'city': 'Koblenz', 'status': 'RECRUITING', 'country': 'Germany', 'facility': 'Galderma Investigational Site 6384', 'geoPoint': {'lat': 50.35357, 'lon': 7.57883}}, {'zip': '23562', 'city': 'Lübeck', 'status': 'RECRUITING', 'country': 'Germany', 'facility': 'Galderma Investigational Site 6013', 'geoPoint': {'lat': 53.86893, 'lon': 10.68729}}, {'zip': '55128', 'city': 'Mainz', 'status': 'RECRUITING', 'country': 'Germany', 'facility': 'Galderma Investigational Site 6373', 'geoPoint': {'lat': 49.98185, 'lon': 8.28008}}, {'zip': '61440', 'city': 'Oberursel', 'status': 'RECRUITING', 'country': 'Germany', 'facility': 'Galderma Investigational Site 6371', 'geoPoint': {'lat': 50.20731, 'lon': 8.57747}}, {'zip': '16515', 'city': 'Oranienburg', 'status': 'RECRUITING', 'country': 'Germany', 'facility': 'Galderma Investigational Site 6411', 'geoPoint': {'lat': 52.75577, 'lon': 13.24197}}, {'zip': '75172', 'city': 'Pforzheim', 'status': 'RECRUITING', 'country': 'Germany', 'facility': 'Galderma Investigational Site 6390', 'geoPoint': {'lat': 48.88436, 'lon': 8.69892}}, {'zip': '6484', 'city': 'Quedlinburg', 'status': 'RECRUITING', 'country': 'Germany', 'facility': 'Galderma Investigational Site 6372', 'geoPoint': {'lat': 51.78843, 'lon': 11.15006}}, {'zip': 'NW3 2QG', 'city': 'London', 'state': 'Hampshire', 'status': 'RECRUITING', 'country': 'United Kingdom', 'facility': 'Galderma Investigational Site 5408', 'geoPoint': {'lat': 51.50853, 'lon': -0.12574}}, {'zip': 'SO16 6YD', 'city': 'Southampton', 'state': 'Hampshire', 'status': 'RECRUITING', 'country': 'United Kingdom', 'facility': 'Galderma Investigational Site 6401', 'geoPoint': {'lat': 50.90395, 'lon': -1.40428}}, {'zip': 'WD18 0HB', 'city': 'Watford', 'state': 'Hertfordshire', 'status': 'RECRUITING', 'country': 'United Kingdom', 'facility': 'Galderma Investigational Site 6399', 'geoPoint': {'lat': 51.65531, 'lon': -0.39602}}, {'zip': 'PE30 4ET', 'city': 'Kings Lynn', 'state': 'Norfolk', 'status': 'RECRUITING', 'country': 'United Kingdom', 'facility': 'Galderma Investigational Site 6400', 'geoPoint': {'lat': 52.75172, 'lon': 0.39516}}, {'zip': 'HG2 7SX', 'city': 'Harrogate', 'state': 'North Yorkshire', 'status': 'RECRUITING', 'country': 'United Kingdom', 'facility': 'Galderma Investigational Site 5131', 'geoPoint': {'lat': 53.99078, 'lon': -1.5373}}, {'zip': 'S10 2TH', 'city': 'Sheffield', 'state': 'South Yorkshire', 'status': 'RECRUITING', 'country': 'United Kingdom', 'facility': 'Galderma Investigational Site 6389', 'geoPoint': {'lat': 53.38297, 'lon': -1.4659}}, {'zip': 'SE5 9RS', 'city': 'London', 'state': 'Surrey', 'status': 'RECRUITING', 'country': 'United Kingdom', 'facility': 'Galderma Investigational Site 6395', 'geoPoint': {'lat': 51.50853, 'lon': -0.12574}}, {'zip': 'B15 2GW', 'city': 'Birmingham', 'state': 'West Midlands', 'status': 'RECRUITING', 'country': 'United Kingdom', 'facility': 'Galderma Investigational Site 6392', 'geoPoint': {'lat': 52.48142, 'lon': -1.89983}}, {'zip': 'LS9 7TF', 'city': 'Leeds', 'state': 'West Yorkshire', 'status': 'RECRUITING', 'country': 'United Kingdom', 'facility': 'Galderma Investigational Site 6404', 'geoPoint': {'lat': 53.79648, 'lon': -1.54785}}, {'zip': 'YO31 8HE', 'city': 'York', 'state': 'Yorkshire', 'status': 'RECRUITING', 'country': 'United Kingdom', 'facility': 'Galderma Investigational Site 6397', 'geoPoint': {'lat': 53.95763, 'lon': -1.08271}}, {'zip': 'CF31 1RQ', 'city': 'Bridgend', 'status': 'RECRUITING', 'country': 'United Kingdom', 'facility': 'Galderma Investigational Site 6375', 'geoPoint': {'lat': 51.50583, 'lon': -3.57722}}, {'zip': 'KT18 7EG', 'city': 'Epsom', 'status': 'RECRUITING', 'country': 'United Kingdom', 'facility': 'Galderma Investigational Site 6388', 'geoPoint': {'lat': 51.3305, 'lon': -0.27011}}, {'zip': 'HA3 7LT', 'city': 'Harrow', 'status': 'RECRUITING', 'country': 'United Kingdom', 'facility': 'Galderma Investigational Site 6394', 'geoPoint': {'lat': 51.57835, 'lon': -0.33208}}, {'zip': 'KT2 7QB', 'city': 'Kingston upon Thames', 'status': 'RECRUITING', 'country': 'United Kingdom', 'facility': 'Galderma Investigational Site 6393', 'geoPoint': {'lat': 51.41259, 'lon': -0.2974}}, {'zip': 'L14 5AB', 'city': 'Liverpool', 'status': 'RECRUITING', 'country': 'United Kingdom', 'facility': 'Galderma Investigational Site 6415', 'geoPoint': {'lat': 53.41058, 'lon': -2.97794}}, {'zip': 'E11 1NR', 'city': 'London', 'status': 'RECRUITING', 'country': 'United Kingdom', 'facility': 'Galderma Investigational Site 5210', 'geoPoint': {'lat': 51.50853, 'lon': -0.12574}}, {'zip': 'SE1 9RT', 'city': 'London', 'status': 'RECRUITING', 'country': 'United Kingdom', 'facility': 'Galderma Investigational Site 6368', 'geoPoint': {'lat': 51.50853, 'lon': -0.12574}}, {'zip': 'M23 2SY', 'city': 'Manchester', 'status': 'RECRUITING', 'country': 'United Kingdom', 'facility': 'Galderma Investigational Site 6396', 'geoPoint': {'lat': 53.48095, 'lon': -2.23743}}, {'zip': 'CH49 5PE', 'city': 'Metropolitan Borough of Wirral', 'status': 'RECRUITING', 'country': 'United Kingdom', 'facility': 'Galderma Investigational Site 6402', 'geoPoint': {'lat': 53.37616, 'lon': -3.10501}}, {'zip': 'RH1 5RH', 'city': 'Redhill', 'status': 'RECRUITING', 'country': 'United Kingdom', 'facility': 'Galderma Investigational Site 5431', 'geoPoint': {'lat': 51.24048, 'lon': -0.17044}}, {'zip': 'CW11', 'city': 'Sandbach', 'status': 'RECRUITING', 'country': 'United Kingdom', 'facility': 'Galderma Investigational Site 6403', 'geoPoint': {'lat': 53.14515, 'lon': -2.36251}}, {'zip': 'SA2 8QA', 'city': 'Swansea', 'status': 'RECRUITING', 'country': 'United Kingdom', 'facility': 'Galderma Investigational Site 5989', 'geoPoint': {'lat': 51.62079, 'lon': -3.94323}}, {'zip': 'WV10 0QP', 'city': 'Wolverhampton', 'status': 'RECRUITING', 'country': 'United Kingdom', 'facility': 'Galderma Investigational Site 5944', 'geoPoint': {'lat': 52.58547, 'lon': -2.12296}}], 'centralContacts': [{'name': 'Galderma Research and Development', 'role': 'CONTACT', 'email': 'clinical.studies@galderma.com', 'phone': '817-961-5000'}]}, 'ipdSharingStatementModule': {'ipdSharing': 'NO'}, 'sponsorCollaboratorsModule': {'leadSponsor': {'name': 'Galderma R&D', 'class': 'INDUSTRY'}, 'responsibleParty': {'type': 'SPONSOR'}}}}